Frontier Medicines

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

• GCGregory ChowExecutive Officer
• LELuke EvninDirector
• JHJohannes Hermann, Ph.D.Executive Officer
• OLOthman LarakiDirector
• JNJanwillem NaesensDirector
• CVChris Varma, Ph.D.Director · Executive Officer
• KWKevin WebsterExecutive Officer
• CWCameron WheelerDirector
• JWJim WinklerExecutive Officer

• 06 Nov 2025Kras G12C Inhibitorsapplication
• 06 May 2025Kras G12C Inhibitorsgranted
• 24 Apr 2025Methods For Treatment Of Cancerapplication
• 20 Mar 2025High-throughput Engineering Of Molecular Gluesapplication
• 30 May 2024Methods And Compounds For Targeted Autophagyapplication
• 06 Jun 2023Methods And Compounds For Targeted Autophagygranted
• 03 Feb 2022Processing Biophysical Screening Data And Identifying And Characterizing Protein Sites For Drug Discoveryapplication
• 03 Feb 2022Processing Biophysical Screening Data And Identifying And Characterizing Protein Sites For Drug Discoveryapplication
• —Pyridopyrimidine Derivative And Uses Thereofapplication
• —P53 Mutant Stabilizer And Uses Thereofapplication
• —Pyridopyrimidine Derivative And Uses Thereofapplication
• —Methods For Treatment Of Cancerapplication

• 07 Jul 2026New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
• 30 Jun 2026Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
• 30 Jun 2026Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
• 29 Jun 2026Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
• 26 Jun 2026Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
• 26 Jun 2026Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.